CRISPR: Ensemble Model

• URL: http://arxiv.org/abs/2403.03018v1
• Date: Tue, 5 Mar 2024 14:55:14 GMT
• Title: CRISPR: Ensemble Model
• Authors: Mohammad Rostami, Amin Ghariyazi, Hamed Dashti, Mohammad Hossein Rohban, Hamid R. Rabiee
• Abstract summary: We propose a novel ensemble learning method for sgRNA design that is accurate and generalizable. Our results suggest that our method can be used to design sgRNAs with high sensitivity and specificity, even for new genes or cells.
• Score: 20.268713698436326
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a gene editing technology that has revolutionized the fields of biology and medicine. However, one of the challenges of using CRISPR is predicting the on-target efficacy and off-target sensitivity of single-guide RNAs (sgRNAs). This is because most existing methods are trained on separate datasets with different genes and cells, which limits their generalizability. In this paper, we propose a novel ensemble learning method for sgRNA design that is accurate and generalizable. Our method combines the predictions of multiple machine learning models to produce a single, more robust prediction. This approach allows us to learn from a wider range of data, which improves the generalizability of our model. We evaluated our method on a benchmark dataset of sgRNA designs and found that it outperformed existing methods in terms of both accuracy and generalizability. Our results suggest that our method can be used to design sgRNAs with high sensitivity and specificity, even for new genes or cells. This could have important implications for the clinical use of CRISPR, as it would allow researchers to design more effective and safer treatments for a variety of diseases.

Related papers

• DeepFM-Crispr: Prediction of CRISPR On-Target Effects via Deep Learning [0.24554686192257422]
  DeepFM-Crispr is a novel deep learning model developed to predict the on-target efficiency and evaluate the off-target effects of Cas13d. It harnesses a large language model to generate comprehensive representations rich in evolutionary and structural data, thereby enhancing predictions of RNA secondary structures and overall sgRNA efficacy.
  arXiv  Detail & Related papers  (2024-09-09T17:33:54Z)
• BEACON: Benchmark for Comprehensive RNA Tasks and Language Models [60.02663015002029]
  We introduce the first comprehensive RNA benchmark BEACON (textbfBEnchmtextbfArk for textbfCOmprehensive RtextbfNA Task and Language Models). First, BEACON comprises 13 distinct tasks derived from extensive previous work covering structural analysis, functional studies, and engineering applications. Second, we examine a range of models, including traditional approaches like CNNs, as well as advanced RNA foundation models based on language models, offering valuable insights into the task-specific performances of these models. Third, we investigate the vital RNA language model components
  arXiv  Detail & Related papers  (2024-06-14T19:39:19Z)
• CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments [51.41735920759667]
  Large Language Models (LLMs) have shown promise in various tasks, but they often lack specific knowledge and struggle to accurately solve biological design problems. In this work, we introduce CRISPR-GPT, an LLM agent augmented with domain knowledge and external tools to automate and enhance the design process of CRISPR-based gene-editing experiments.
  arXiv  Detail & Related papers  (2024-04-27T22:59:17Z)
• Machine Learning Modeling Of SiRNA Structure-Potency Relationship With Applications Against Sars-Cov-2 Spike Gene [0.0]
  Drug discovery process is lengthy and costly, taking nearly a decade to bring a new drug to the market. Biotechnology, computational methods, and machine learning algorithms have the potential to revolutionize drug discovery, speeding up the process and improving patient outcomes. The COVID-19 pandemic has further accelerated and deepened the recognition of the potential of these techniques, especially in the areas of drug repurposing and efficacy predictions.
  arXiv  Detail & Related papers  (2024-01-18T23:00:34Z)
• scHyena: Foundation Model for Full-Length Single-Cell RNA-Seq Analysis in Brain [46.39828178736219]
  We introduce scHyena, a foundation model designed to address these challenges and enhance the accuracy of scRNA-seq analysis in the brain. scHyena is equipped with a linear adaptor layer, the positional encoding via gene-embedding, and a bidirectional Hyena operator. This enables us to process full-length scRNA-seq data without losing any information from the raw data.
  arXiv  Detail & Related papers  (2023-10-04T10:30:08Z)
• Improving RNA Secondary Structure Design using Deep Reinforcement Learning [69.63971634605797]
  We propose a new benchmark of applying reinforcement learning to RNA sequence design, in which the objective function is defined to be the free energy in the sequence's secondary structure. We show results of the ablation analysis that we do for these algorithms, as well as graphs indicating the algorithm's performance across batches.
  arXiv  Detail & Related papers  (2021-11-05T02:54:06Z)
• Machine learning for plant microRNA prediction: A systematic review [0.0]
  MicroRNAs (miRNAs) are endogenous small non-coding RNAs that play an important role in gene regulation. computational and machine learning-based approaches have been adopted to predict microRNAs. This systematic review focuses on the machine learning methods developed for identification in plants.
  arXiv  Detail & Related papers  (2021-06-29T08:22:57Z)
• Machine Learning Against Cancer: Accurate Diagnosis of Cancer by Machine Learning Classification of the Whole Genome Sequencing Data [0.0]
  We have developed novel methods of MLAC (Machine Learning Against Cancer) achieving perfect results with perfect precision, sensitivity, and specificity. We have used the whole genome sequencing data acquired by next-generation RNA sequencing techniques in The Cancer Genome Atlas and Genotype-Tissue Expression projects for cancerous and healthy tissues respectively.
  arXiv  Detail & Related papers  (2020-09-12T18:51:47Z)
• Select-ProtoNet: Learning to Select for Few-Shot Disease Subtype Prediction [55.94378672172967]
  We focus on few-shot disease subtype prediction problem, identifying subgroups of similar patients. We introduce meta learning techniques to develop a new model, which can extract the common experience or knowledge from interrelated clinical tasks. Our new model is built upon a carefully designed meta-learner, called Prototypical Network, that is a simple yet effective meta learning machine for few-shot image classification.
  arXiv  Detail & Related papers  (2020-09-02T02:50:30Z)
• A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning [49.86828302591469]
  We train >35,000 neural network models, sweeping over common featurization techniques. We found the RNA-seq to be highly redundant and informative even with subsets larger than 128 features.
  arXiv  Detail & Related papers  (2020-04-30T20:42:17Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.